SUNGKWANG MEDICAL FOUNDATION

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUNGKWANG MEDICAL FOUNDATION.The latest application filed is for "method for preparing matrilin-3 pretreated stem cell speroids, and composition, derived therefrom, for preventing or treating cartilage diseases".

Company Profile

16.11.30

SUNGKWANG MEDICAL FOUNDATION - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Method For Preparing Matrilin-3 Pretreated Stem Cell Speroids, And Composition, Derived Therefrom, For Preventing Or Treating Cartilage Diseases App 20220296649 - HAN; In Bo ; et al.	2022-09-22
Nanovesicles From Adult Stem Cells And Its Use For Targeted Therapy App 20220249570 - Kim; Byung-Soo ; et al.	2022-08-11
IDO-TDO dual inhibitor and related methods of use Grant 11,370,758 - Jeon , et al. June 28, 2	2022-06-28
Fibrosis-inducing Drug-eluting Stent For Blocking Electric Conduction App 20220168121 - SUNG; Jung Hoon ; et al.	2022-06-02
Composition, Kit, And Method For Diagnosis And Treatment Of Taxane Anticancer Agent-resistant Cancer App 20220119888 - AN; Hee Jung ; et al.	2022-04-21
A Composition Comprising Mesenchymal Stem Cells For Inhibiting Adipogenesis App 20220010280 - KIM; Gi Jin ; et al.	2022-01-13
Synthesis method of DHPV Grant 11,214,558 - Kim , et al. January 4, 2	2022-01-04
Composition For Culturing Nk Cells And Method For Culturing Nk Cells Using Same App 20210095249 - AN; Hee Jung ; et al.	2021-04-01
Novel Synthesis Method Of Dhpv App 20210040056 - KIM; David Tae Aug ; et al.	2021-02-11
Composition For Treatment Of Thyroid Associated Ophthalmopathy, Comprising Mesenchymal Stem Cell App 20200246392 - Kind Code	2020-08-06
Method for diagnosing and treating ovarian cancer Grant 10,538,817 - An , et al. Ja	2020-01-21
Pcnt As A Target Protein For Treatment Or Diagnosis Of Brain-nervous System Diseases App 20190336541 - KIM; Minyoung ; et al.	2019-11-07
Ido-tdo Dual Inhibitor And Related Methods Of Use App 20190292150 - JEON; Hong Jae ; et al.	2019-09-26
Composition For Preventing, Improving Or Treating Photoaging Of Skin Comprising Dhpv App 20190021976 - KIM; David Tae Aug ; et al.	2019-01-24
Method For Diagnosing And Treating Ovarian Cancer App 20190002991 - AN; Hee Jung ; et al.	2019-01-03
Placenta-derived Cells Excreting C3 Or C1r Complement And Composition Containing Same App 20180280447 - MOON; Ji Sook ; et al.	2018-10-04
Method for diagnosing and treating ovarian cancer Grant 10,060,926 - An , et al. August 28, 2	2018-08-28
Storage Method And Banking System Of Nt Cell App 20180208891 - CHA; Kwang Yul ; et al.	2018-07-26
Method For Diagnosing And Treating Ovarian Cancer App 20180095087 - AN; Hee Jung ; et al.	2018-04-05
Composition, kit, and method for diagnosing and treating ovarian cancer Grant 9,915,661 - An , et al. March 13, 2	2018-03-13
Composition Including Mesenchymal Stem Cell Derived From Adipose Tissues And Hyaluronic Acid Derivative, Method Of Preparing The Same, And Method Of Preventing Or Treating Low Back Pain Using The Same App 20180021380 - HAN; Inbo ; et al.	2018-01-25
Process of preparing human multipotent stem cells co-expressing CD34 and CD73 Grant 9,688,961 - Lee , et al. June 27, 2	2017-06-27
Composition, Kit, And Method For Diagnosing And Treating Ovarian Cancer App 20170153240 - AN; Hee Jung ; et al.	2017-06-01
Testis Somatic Cell-derived Pluripotent Stem Cells, Method For Producing Same, And Pharmaceutical Composition For Impotence Treatment Including Same App 20140120070 - Lee; Dong-Ryul ; et al.	2014-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.